| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |